GM Advisory Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Buy
3,842
+84
+2% +$42.5K 0.07% 117
2025
Q4
$2.13M Buy
3,758
+16
+0.4% +$8.52K 0.08% 104
2025
Q3
$1.67M Sell
3,742
-441
-11% -$212K 0.07% 111
2025
Q2
$2.27M Buy
4,183
+14
+0.3% +$7.32K 0.11% 90
2025
Q1
$2.06M Sell
4,169
-71
-2% -$39.3K 0.11% 80
2024
Q4
$2.21M Sell
4,240
-31
-0.7% -$16.1K 0.12% 77
2024
Q3
$2.1M Buy
4,271
+58
+1% +$27K 0.13% 77
2024
Q2
$1.87M Buy
4,213
+141
+3% +$56.2K 0.12% 78
2024
Q1
$1.63M Buy
4,072
+6
+0.1% +$2.27K 0.11% 83
2023
Q4
$1.37M Buy
4,066
+174
+4% +$51.9K 0.1% 77
2023
Q3
$1.14M Buy
3,892
+156
+4% +$48.7K 0.09% 73
2023
Q2
$1.28M Buy
3,736
+115
+3% +$34.8K 0.11% 70
2023
Q1
$925K Hold
3,621
0.08% 79
2022
Q4
$961K Hold
3,621
0.1% 73
2022
Q3
$679K Buy
+3,621
New +$778K 0.09% 88
2022
Q1
Sell
-603
Closed -$217K 208
2021
Q4
$217K Buy
+603
New +$207K 0.02% 188

Other funds holding ISRG

GM Advisory Group's ISRG Position: Q1 2026 in Review

GM Advisory Group increased its Intuitive Surgical (ISRG) stake by 2.2% in Q1 2026, buying an estimated $42.5K and bringing the position to 3,842 shares worth $1.77M. The position accounts for 0.07% of the portfolio, ranked #117.

GM Advisory Group first reported a position in ISRG in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.27M in Q2 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • GM Advisory Group held 3,842 shares of Intuitive Surgical worth $1.77M as of Q1 2026.
  • GM Advisory Group bought 84 Intuitive Surgical shares in Q1 2026, an estimated $42.5K.
  • Intuitive Surgical made up 0.07% of GM Advisory Group's portfolio in Q1 2026, its #117 holding.
  • GM Advisory Group first reported a position in Intuitive Surgical in Q4 2021 and has held it in 16 quarters since.
  • GM Advisory Group's Intuitive Surgical position peaked at $2.27M in Q2 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.